pharmaceutical investing InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
pharmaceutical investing InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance
pharmaceutical investing InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program
pharmaceutical investing InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
pharmaceutical investing InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
pharmaceutical investing InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
pharmaceutical investing InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901
Metalsource Mining Extends Strike Length of Mineralization at Silver Hill with 65m South Step Out from SH26-19
Bold Ventures Identifies Widespread Rare Earth Element Anomalies at Burchell, Plans Next Phase of Exploration
Purecore Signs Definitive Agreement with Skyharbour for Yurchison Uranium Property Option in Athabasca Basin
Skyharbour Signs Definitive Agreement with Purecore to Option its Yurchison Uranium Property in the Athabasca Basin
NevGold Appoints Scott Bensing as Independent Non-Executive Director; Key US-Based External And Government Relations Board Appointment To Support Strategic Initiatives
